Provexis plc
Research Provexis plc (NZCA) on Bullrun: market cap EUR 21.11M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerNZCA
- ExchangeF
- CountryUnited Kingdom
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyEUR
- Market capEUR 21.11M
- Financial periodFY2025
- RevenueGBP 1.29M
- Revenue growth61.1%
- Net income-GBP 452.72K
- Free cash flow-GBP 340.83K
- Gross margin41.2%
Valuation Snapshot
latest market cap is EUR 21.11M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | GBP 1.29M | -GBP 452.72K | -GBP 340.83K | 41.2% | n/a | GBP 708.09K | n/a | GBP 1.30M |
| FY2024 | GBP 801.96K | -GBP 586.24K | -GBP 191.50K | 35.4% | 0 | GBP 189.36K | n/a | GBP 724.34K |
| FY2023 | GBP 389.92K | -GBP 385.24K | -GBP 520.74K | 75.5% | 0 | GBP 379.12K | n/a | GBP 1.19M |
| FY2022 | GBP 426.17K | -GBP 224.25K | -GBP 213.62K | 89.2% | 0 | GBP 863.87K | n/a | GBP 1.50M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-14 | EUR 21.11M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About Provexis plc
Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. The company offers syrup and powder versions of Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke used in various foods, beverages, and dietary supplement formats. It also provides Fruitflow+ Omega-3, a dietary supplement product.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Provexis plc's market cap?
Provexis plc's market capitalization is EUR 21.11M.
What does Provexis plc do?
Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. The company offers syrup and powder versions of Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke used in various foods, beverages, and dietary supplement formats. It also provides Fruitflow+ Omega-3, a dietary supplement product. The company sells its products through e-commerce website and distributors.